Drreddys Laboratories reported $13.89B in EBITDA for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Ani Pharmaceuticals ANIP:US $ -4.64M 2.68M
Aurora Cannabis Inc ACB:CN -88561000 17.03M
Canopy Growth Corp WEED:CN C$ -273741000 191.85M
Catalent CTLT:US $ 315M 39M
Cipla CIPLA:IN IR 7497.2M 4812.5M
Corcept Therapeutics CORT:US $ 27.06M 9.9M
Endo International Ordinary Shares ENDP:US $ 226.56M 52.35M
GlaxoSmithKline GSK:LN 3120M 1062M
Hikma Pharmaceutical HIK:LN 368M 10M
Horizon Pharma HZNP:US $ 291.56M 100.61M
JAZZ PHA JAZZ:US $ 267.26M 90.66M
Lannett LCI:US $ -12.48M 3.96M
Lonza Group LONN:SW 789M 58M
Novartis NOVN:VX SF 4552M 346M
Pacira Pharmaceuticals PCRX:US $ 41.76M 17.12M
Phibro Animal Health PAHC:US $ 27.64M 2.66M
Prestige Brands PBH:US $ 85.91M 4.73M
Richter Gedeon RICHT:HB 49.12B 8.95B
Sun Pharmaceuticals SUNP:IN IR 21793.5M 4375.7M
Supernus Pharmaceuticals SUPN:US $ 23.33M 17.79M
Teva Pharmaceutical TEVA:IT 1.11B 176M